Serum phosphatidylserine-specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity.
Tetsuji SawadaMakoto KuranoHarumi ShiraiYukiko IwasakiKoichiro TaharaHaeru HayashiKoji IgarashiKeishi FujioJunken AokiYutaka YatomiPublished in: International journal of rheumatic diseases (2019)
Serum PS-PLA1 is associated with disease activity of SLE, indicating its possible use as a biomarker for monitoring SLE disease activity.